|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0085415,
umls-concept:C0205263,
umls-concept:C0220901,
umls-concept:C0332283,
umls-concept:C0441771,
umls-concept:C0441833,
umls-concept:C1516238,
umls-concept:C1519810,
umls-concept:C1707455
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-8-25
|
|
pubmed:abstractText |
In Cancer and Leukemia Group B 39801, we evaluated whether induction chemotherapy before concurrent chemoradiotherapy would result in improved survival and demonstrated no significant benefit from the addition of induction chemotherapy. The primary objective of this analysis was to dichotomize patients into prognostic groups using factors predictive of survival and to investigate whether induction chemotherapy was beneficial in either prognostic group.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA02599,
http://linkedlifedata.com/resource/pubmed/grant/CA03927,
http://linkedlifedata.com/resource/pubmed/grant/CA04326,
http://linkedlifedata.com/resource/pubmed/grant/CA04457,
http://linkedlifedata.com/resource/pubmed/grant/CA07968,
http://linkedlifedata.com/resource/pubmed/grant/CA08025,
http://linkedlifedata.com/resource/pubmed/grant/CA11028,
http://linkedlifedata.com/resource/pubmed/grant/CA11789,
http://linkedlifedata.com/resource/pubmed/grant/CA12046,
http://linkedlifedata.com/resource/pubmed/grant/CA12449,
http://linkedlifedata.com/resource/pubmed/grant/CA16450,
http://linkedlifedata.com/resource/pubmed/grant/CA21060,
http://linkedlifedata.com/resource/pubmed/grant/CA26806,
http://linkedlifedata.com/resource/pubmed/grant/CA29165,
http://linkedlifedata.com/resource/pubmed/grant/CA31946,
http://linkedlifedata.com/resource/pubmed/grant/CA31983,
http://linkedlifedata.com/resource/pubmed/grant/CA32291,
http://linkedlifedata.com/resource/pubmed/grant/CA33601,
http://linkedlifedata.com/resource/pubmed/grant/CA35421,
http://linkedlifedata.com/resource/pubmed/grant/CA37135,
http://linkedlifedata.com/resource/pubmed/grant/CA41287,
http://linkedlifedata.com/resource/pubmed/grant/CA41287333,
http://linkedlifedata.com/resource/pubmed/grant/CA45389,
http://linkedlifedata.com/resource/pubmed/grant/CA45564,
http://linkedlifedata.com/resource/pubmed/grant/CA45808,
http://linkedlifedata.com/resource/pubmed/grant/CA47555,
http://linkedlifedata.com/resource/pubmed/grant/CA47559,
http://linkedlifedata.com/resource/pubmed/grant/CA47577,
http://linkedlifedata.com/resource/pubmed/grant/CA47642,
http://linkedlifedata.com/resource/pubmed/grant/CA71323,
http://linkedlifedata.com/resource/pubmed/grant/CA74811,
http://linkedlifedata.com/resource/pubmed/grant/CA77298,
http://linkedlifedata.com/resource/pubmed/grant/CA77440,
http://linkedlifedata.com/resource/pubmed/grant/CA77597,
http://linkedlifedata.com/resource/pubmed/grant/CA77658,
http://linkedlifedata.com/resource/pubmed/grant/CA86726,
http://linkedlifedata.com/resource/pubmed/grant/U10 CA031946-28
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
pubmed-author:AkerleyWallaceW,
pubmed-author:AtkinsJames NJN,
pubmed-author:Cancer and Leukemia Group B,
pubmed-author:CicchettiM GiuliaMG,
pubmed-author:GreenMark RMR,
pubmed-author:HerndonJames EJE2nd,
pubmed-author:HodgsonLydiaL,
pubmed-author:KelleyMichael JMJ,
pubmed-author:NiellHarvey BHB,
pubmed-author:RamnathNithyaN,
pubmed-author:StinchcombeThomas ETE,
pubmed-author:VokesEverett EEE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1117-25
|
|
pubmed:dateRevised |
2010-9-7
|
|
pubmed:meshHeading |
pubmed-meshheading:19652624-Adult,
pubmed-meshheading:19652624-Aged,
pubmed-meshheading:19652624-Aged, 80 and over,
pubmed-meshheading:19652624-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19652624-Clinical Trials as Topic,
pubmed-meshheading:19652624-Combined Modality Therapy,
pubmed-meshheading:19652624-Female,
pubmed-meshheading:19652624-Humans,
pubmed-meshheading:19652624-Lung Neoplasms,
pubmed-meshheading:19652624-Male,
pubmed-meshheading:19652624-Middle Aged,
pubmed-meshheading:19652624-Neoplasm Staging,
pubmed-meshheading:19652624-Prognosis,
pubmed-meshheading:19652624-Proportional Hazards Models,
pubmed-meshheading:19652624-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
|
|
pubmed:affiliation |
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7305, USA. thomas_stinchcombe@med.unc.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, N.I.H., Extramural
|
